A novel method for generating naive human iPS cells with significantly higher differentiation potency
A joint research team led by Dr. Akira Kunitomi, a former postdoctoral fellow at CiRA (currently a researcher at the Gladstone Institute of Cardiovascular Disease), and ID Pharma Co., Ltd., has established a new method for ...
